Polen Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,248
Closed -$784K 122
2024
Q4
$784K Sell
4,248
-1,256
-23% -$242K ﹤0.01% 113
2024
Q3
$1.08M Sell
5,504
-211
-4% -$43.9K ﹤0.01% 101
2024
Q2
$1.18M Sell
5,715
-345
-6% -$78.2K ﹤0.01% 97
2024
Q1
$1.64M Sell
6,060
-268
-4% -$64K ﹤0.01% 92
2023
Q4
$1.5M Buy
6,328
+1,323
+26% +$260K ﹤0.01% 101
2023
Q3
$981K Buy
5,005
+50
+1% +$10.3K ﹤0.01% 94
2023
Q2
$1.04M Sell
4,955
-514
-9% -$102K ﹤0.01% 92
2023
Q1
$1.1M Sell
5,469
-219
-4% -$49.6K ﹤0.01% 89
2022
Q4
$1.24M Buy
5,688
+1,038
+22% +$227K ﹤0.01% 85
2022
Q3
$915K Sell
4,650
-35
-0.7% -$7.56K ﹤0.01% 81
2022
Q2
$1M Buy
+4,685
New +$1.14M ﹤0.01% 80

Other funds holding CRL